General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
Bronchiectasis Industry Awareness Campaign
Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential We are collaborating with industry experts and Asthma +Lung…
-
NEURii
Transforming care for people living with dementia through UK-based collaboration, NEURii. In partnership with Eisai, Gates Ventures, Health Data Research…
-
LifeArc Translational Centres for Rare Diseases
LifeArc Translational Centres for Rare Diseases We have invested £40 million into 4 Translational Centres for Rare Diseases, to unlock…
-
Grand Challenges African Drug Discovery Accelerator programme
Supporting drug discovery projects in sub-Saharan Africa with the Grand Challenges African Drug Discovery Accelerator programme In collaboration with the…
-
FIND
Helping eliminate visceral leishmaniasis in Kenya with FIND We have partnered with the not-for-profit organisation, FIND, to help eliminate visceral…
-
ReACT Africa
Tackling drug-resistant infections with ReACT Africa In partnership with ReAct (Action on Antibiotic Resistance) Africa, we have launched ASPIRE, a…
-
The Francis Crick Institute and the Crick Africa Network
The Francis Crick Institute and the Crick Africa Network A partnership with the Crick Africa Network (CAN) in collaboration with…
-
PACE: Pathways to Antimicrobial Clinical Efficacy
PACE: Pathways to Antimicrobial Clinical Efficacy PACE is a £30 million collaborative initiative to help progress new developments to tackle…
-
TB-MBLA
TB-MBLA A potential test for both diagnosis and monitoring of TB over time. For the last five years, LifeArc has…
-
LifeArc-CSO fund for Scottish translational researchers
LifeArc-CSO fund for Scottish translational researchers In association with the Chief Scientist Office (CSO) for the Scottish Government, we support…
-
LifeArc gene therapy innovation fund
LifeArc gene therapy innovation fund The LifeArc Gene Therapy Innovation Fund is a £5m annual fund to support manufacture of…